HIGHLIGHTS
- who: Toshiya Kuno and colleagues from the Department of Experimental Pathology and Tumor Biology, Graduate School of Medical Sciences, Department of Tumor Pathology, Graduate School of Medicine, Gifu University, Gifu Municipal Hospital, Gifu, Japan have published the Article: The Peroxisome Proliferator-Activated Receptor (PPAR) α Agonist Fenofibrate Suppresses Chemically Induced Lung Alveolar Proliferative Lesions in Male Obese Hyperlipidemic Mice, in the Journal: (JOURNAL)
- what: This study was designed to determine whether fenofibrate a PPARα agonist can suppress (4-NQO)-induced proliferative lesions in lung of obese Male Tsumura Suzuki Obese Diabetic were subcutaneously injected with 4 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.